Early Phase 1 Prostate Cancer Trial, Recruiting NCT06756334 Sponsor: Anhui Provincial Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Early Phase 1 Prostate Cancer Trial, Recruiting

NCT06756334
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Be between 18 and 90 years old
  • Have complete MRI scans and medical records available (such as PSA blood test results and cancer grading information)
  • Have prostate cancer found through a PSA blood test or imaging scan, or be suspected of having the cancer come back after standard treatment
  • Be able to have two specific types of PET scans (called [18F]AlF-PSMA-N5 and [18F]F-DCFPyL) within two weeks of each other
  • Be willing to have surgery or a needle biopsy to confirm the diagnosis after the scans, or have already had prostate cancer confirmed by a tissue sample before or after treatment
  • Be willing to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • People who are unable to cooperate with or complete the required examinations
  • People who currently have another type of cancer at the same time
  • People who have had an allergic reaction to alcohol in the past
  • People who have liver or kidney problems that are not working properly
  • People who the trial doctors decide are not suitable to participate for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Qiang Xie, MD, The First Affiliated Hospital of China University of Science and Technology(Anhui Provincial Hospital)

Phone: 13721108043

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Anhui Provincial Hospital
Registry
ClinicalTrials.gov
Start date
19 December 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Standard uptake value(SUV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov